Chinese inhibitor drug candidate becomes first to enter phase
Release time：2024-05-01 02:31:31 Source：World Wander news portal
Chinese biotech company Jacobio Pharma announced on Monday that it had received approval from Chinese regulatory authorities for the registration phase-3 clinical trial of a combination therapy using its SHP2 inhibitor drug candidate JAB-3312.
SHP2 inhibitors are expected worldwide to have a substantial clinical effect in cancer and immunity disease treatment, and the approval made JAB-3312 the first SHP2 inhibitor to enter the phase-3 clinical study globally.
The approved clinical study in China is designed to evaluate the efficacy and safety of JAB-3312 in combination with the company's other investigational drug candidate KRAS G12C inhibitor glecirasib, for treating first-line non-small cell lung cancer patients with KRAS G12C mutations.
The control arm is the current standard treatment for first-line non-small cell lung cancer, which is the combination therapy of PD-1 antibody and chemotherapy.
- Previous：Rays reliever Chris Devenski goes on the injured list with knee tendinitis
- Next：Michael Sheen looks unrecognisable as Prince Andrew in first look at Amazon's A Very Royal Scandal
Related articles
- FDA brings lab tests under federal oversight in bid to improve accuracy and safety
- Hanjiang River in south China sees 2nd flood of 2024
- China's proactive opening up expands mutual dividends
- The Village Super League and the rural awakening
- 3 dead, 4 missing in explosion at Italy power station
- China activates Level
- Obstacles remain as women seek more leadership roles in America's Black Church
- Jiangsu edge Guangzhou to snap 17
- Spanish city of Barcelona celebrates day of books and love
- Messi: I'll retire when I can't help my team
- Trump and DeSantis make peace, talk fundraising for election 2024
- 'Ice city' sees booming tourism
- Int'l travel expo kicks off in Macao
- Foreigners' tours in China to be more convenient: minister
- A gunman kills 6 worshippers inside a Shiite mosque in western Afghanistan, the Taliban say
- Ancient villages boost tourism by innovation in Hebei
- Chinese vice premier urges intensified emergency rescue, flood response work
- Dubai plans to move its busy international airport to a $35 billion new facility within 10 years
- Suspected al
- State Councilor stresses need for elderly care meal services, continuous post
Random recommendation
- Copyright © 2024 Powered by Chinese inhibitor drug candidate becomes first to enter phase ,World Wander news portal sitemap